Pfizer (PFE) Falls 2%, Sarepta Therapeutics (SRPT) Up on Chatter of Death in Pfizer’s DMD Trial

Visit StreetInsider.com at http://www.streetinsider.com/Hot+FDA+News/Pfizer+%28PFE%29+Falls+2%25%2C+Sarepta+Therapeutics+%28SRPT%29+Up+on+Chatter+of+Death+in+Pfizer%27s+DMD+Trial/23185911.html for the full story.